Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AATV .65 - exciting news: ...Compared to the Company's remarkable fourth quarter of 2020, the Company's largest revenue for any fourth quarter throughout the Company's history was about $2.74 million in 2018. Revenue recorded for the fourth quarter of 2020 exceeded $5.71 million, for an increase of more than double from that prior largest quarter...
https://www.otcmarkets.com/stock/AATV/news/Adaptive-Ad-Systems-Announces-Record-Revenue-For-4th-Quarter-2020-Exceeding-571-Million?id=289072
Donde esta las robinhooligans?
DURECT Corporation Announces U.S. FDA Approval of POSIMIR® For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression
https://www.marketwatch.com/press-release/durect-corporation-announces-us-fda-approval-of-posimir-for-post-surgical-pain-reduction-for-up-to-72-hours-following-arthroscopic-subacromial-decompression-2021-02-02?siteid=bigcharts&dist=bigcharts&tesla=y
Any renewed interest? Anyone?
CTHR - here here, entered at 2.25 on your earlier post. Keep em coming hot while the robinhooligans continue throwing money at the wall incoherently...
Getting some positive pps interest in the past few days...anyone heard anything new re: "the 069 patent"?
Maybe us retail shareholders will get an update in the 10K filing due in a few weeks?
VXRT - ...neutralizing antibodies were not detected in serum...
Does this suggest that a follow-up Phase-2 trial for "VXA-CoV2-1" will likely get scrapped? That would be devastating to the current $11's pps?
CATB - agreed, the trade does carry some considerable risk.
Question: as did the regular "stock" volume and price go nuts on Friday, so did the "option" volume and price go nuts...so...does the present mega-increase in "option" volume serve to support the regular "stock" price?
ASMB may have the lowest EV/cash ratio among biotechs right now.
I believe that is correct and unusual in that there have always seemed to be several trading at 1/2-tangible-book in the 10 years or so that I've been interested the cashfat-biobusts.
ASMB - fundamentals be glorious while utilizing HE-money (hard earned)!
Stupid is as Stupid does, n'est ce pas?
ASMB 5.58 - re-entered here. I'm showing approx. $8 in tangible BV (at 9/30/20) within a broad-market of absolute lunacy in forming hockey-stick-charts.
ASMB 5.58 - re-entered here for a second go-round. I'm showing approx. $8 in tangible BV (at 9/30/20) within a broad-market of absolute lunacy in forming hockey-stick-charts.
RIGL 3.64 - Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
https://ih.advfn.com/stock-market/NASDAQ/rigel-pharmaceuticals-RIGL/stock-news/84206472/rigel-awarded-16-5-million-from-u-s-department-o
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
https://ih.advfn.com/stock-market/NASDAQ/rigel-pharmaceuticals-RIGL/stock-news/84206472/rigel-awarded-16-5-million-from-u-s-department-o
Just nod if you can hear me
Is there anybody home
Can you link that post from WallStreetBets?
RIGL 3.65 - added on this news just out...
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
https://finance.yahoo.com/news/rigel-awarded-16-5-million-194500483.html
CATB 4.80 - this cashfat biobust has been on my watch for months. Basically a shell, they announced a merger with another bio this morning, shot off like a rocket, and are currently offering an approx. 30% on covered calls expiring in 3 weeks (Feb 19).
I've been snatching a pocketful this morning...
HTBX 7.15 - opens for option-trading just this morning...
New option listings for January 29th include Heat Biologics(HTBX).
I've been trading this 2nd tier vaccine stock for months. Now I'll be even more eager to trade this stock with the additional covered-call-premiums benefit.
And a golden opp to observe an option-class from it's infancy. IMO options-trading is most similar to pennystock trading...wide spreads, low volume, and mandatory to try to enjoy dickering with the greedy mm's.
AATV - not sure about 'seasonality' but with our current covid-phenomenon, I think any past 'seasonality' would no longer be relevant in the shortterm? Thru all their BS, hyperbole or whatever one wants to call it, I found this paragraph from the CEO to be the most convincing:
December 2, 2020 - Mr. Heil continues: "Despite America's quadrennial election-cycle-spending having largely stalled from March through June and even July, by August most candidates and their parties were fully deploying funds for television advertising. And, while we expected the late-summer trend of increased ad frequency throughout our network to continue, the political ad spending during the final months of the election was simply unprecedented. Based on the Georgia runoff elections that again present the market with enormous ad spending, we expect this trend to continue through January of 2021."
https://www.otcmarkets.com/stock/AATV/news/Adaptive-Ad-Systems-Reports-Two-More-Record-Months-for-October--November-2020?id=282216
What's your wag on the upcoming Q4 numbers? Any other posters with an AATV wag?
AATV .565 - still trying to get a read on how to interpret the plethora of pr's from these guys. My math shows they produced $2,747,000-revenue in Q4/2018.
So, my wag for Q4/2020 is $3M+ revenue. If they can duplicate (or increase) that Q3/2020 eps-number of ".035" on $3.5M revenue...voila
Added several shares more today at .41.
AATV .565 - still trying to get a read on how to interpret the plethora of pr's from these guys. My math shows they produced $2,747,000-revenue in Q4/2018.
So, my wag for Q4/2020 is $3M+ revenue. If they can duplicate (or increase) that Q3/2020 eps-number of ".035" on $3.5M revenue...voila
Added several shares more today at .41.
AATV .54 - revenue update:
Prior to the conclusion of the month of December 2020, the Company's largest revenue for any December throughout the company's history was $429,000. Revenue recorded for December 2020 exceeded $1.3 million, for an increase of about 200%.
The record revenue for December 2020 adds to the exceptional financial performance during all of 2020. The Company had already reported record revenue for each of the months of August and September of 2020, which resulted in the largest third quarter revenue ever, only to be surpassed again by the largest revenue for any months of October and November.
Mr. Heil states: "The year 2020 was a challenging year for almost every business, and our company was no exception. However, through regular remote conferencing by our team, persistence in installing new and advanced ad-insertion equipment, upgrading existing equipment, continuing to improve our digital ad insertion software technology and working closely with advertisers who were trying to adjust quickly to a unique advertising environment, we were able to achieve, and even exceed, many of the goals we set back in January 2020. Accordingly, I am pleased to announce that while having produced extraordinary gains in revenue over the past five months, we currently anticipate reporting soon the largest revenue for any January in the Company's history."
https://www.otcmarkets.com/stock/AATV/news/Adaptive-Ad-Systems-Announces-Record-Revenue-of-13-Million-for-December-2020?id=287594
AATV .54 - revenue update:
Prior to the conclusion of the month of December 2020, the Company's largest revenue for any December throughout the company's history was $429,000. Revenue recorded for December 2020 exceeded $1.3 million, for an increase of about 200%.
The record revenue for December 2020 adds to the exceptional financial performance during all of 2020. The Company had already reported record revenue for each of the months of August and September of 2020, which resulted in the largest third quarter revenue ever, only to be surpassed again by the largest revenue for any months of October and November.
Mr. Heil states: "The year 2020 was a challenging year for almost every business, and our company was no exception. However, through regular remote conferencing by our team, persistence in installing new and advanced ad-insertion equipment, upgrading existing equipment, continuing to improve our digital ad insertion software technology and working closely with advertisers who were trying to adjust quickly to a unique advertising environment, we were able to achieve, and even exceed, many of the goals we set back in January 2020. Accordingly, I am pleased to announce that while having produced extraordinary gains in revenue over the past five months, we currently anticipate reporting soon the largest revenue for any January in the Company's history."
https://www.otcmarkets.com/stock/AATV/news/Adaptive-Ad-Systems-Announces-Record-Revenue-of-13-Million-for-December-2020?id=287594
Nothing has convinced me that we’re in a bubble more than this video. https://t.co/P6wohCVNkQ
— Dare Obasanjo🐀 (@Carnage4Life) January 17, 2021
You don't include SNFCA in that list? SNFCA has the best 'value' numbers of any stock I see.
It is though everyone has taken LSD and entered a casino...inside a cuckoo's nest
NBIO .08 - getting some of this looney-love...anyone have a report of any 'magician-guru' somewhere touting it to da moon...
SFIX 95.70 - entered a tiny 50 shares short position. Haven't shorted or put anything in months but HIGHtime (pun intended) has came something needs to be did...
Little bit of trying to time the market here with this trade but I'm with you 100% on awaiting earnings releases. Wish there were more discussion here RE:
'highflyingpigs with an earnings miss expectation'
SFIX 81.80 - in the what-I-see-as-inevitable market collapse (when the robinherd'ers all whine in unison, "The rich corporate insiders robbed us unmercifully and just a bit deceitfully!"...DUH!!! then this stock SFIX should make for one of a plethora of excellent shorts?
What's your current take here?
Brilacidin is one of the few drugs targeting COVID-19 that has been tested in human trials (a total of 8) for other clinical indications, providing established safety and efficacy data on over 460 subjects, thereby potentially enabling it to rapidly help address the novel coronavirus crisis.
Touting 8 previous trials but no tout on any advancement of those previous 8? hhhmmmmm...All Hat - No Cattle???
IPIX Marketcap = $100M (not touching it at this price)
NBIO Marketcap = $6M (currently my #1 position)
https://www.otcmarkets.com/stock/NBIO/profile
Chimerix Inc. (CMRX) shares were up 10% to $10.04 after the company priced its underwritten public offering of 11.8 million shares of common stock at $8.50 a share. The stock hit its 52-week high of $10.72 earlier in the session.
And the beat goes on...
Now 300k on the ask at .0645. Seriously Clark, this seller insults our intelligence with this ludicrous bluff! NBIO doesn't trade 300k volume in a week....
CMRX 8.82 (+ .72) - filed a $75M shelf in afterhours yesterday.
WWWWWEEEEEEEEEEE...money grows on treeeeeeeeeeees
CLBS 3.70 - I bought at 1.60 in premarket yesterday on yesterday morning's premarket news which I thought was very good...then sold at 1.61 later yesterday afternoon when nothing happened? Woke up this morning to a premarket open of 3.50+ (on no new news).
Was I 24 hours too fast? Robinherd'ers are 24 hrs behind?? Possibly your 'deadnsyde' guru grapt-a-holt??? Whoa is me????
P1 results this month would be most probable.
Can you elaborate?
SSET - because it's a "SPAC", it's desirable?
...I don't have one open buy order...
Ditto, and I usually have at least 5 or so lowball-gtc-bids on various stocks.
Using GME and BEEM as current examples of EXTREMELY STUPID BUYING, can we anticipate seeing some reciprocal EXTREMELY STUPID SELLING?
someone mentioned "bunker"...time to hunker in the bunker???
BGFV - didn't watch but all risk of a Q4 miss seems to have been eliminated with this ".90 to .93" exact estimate. Seems extremely low-risk now at $12's pps in comparison to any of it's 'value-stock' peers.
For the fiscal 2020 fourth quarter, the Company now expects to generate earnings per diluted share in the range of $0.90 to $0.93, including a benefit of $0.10 per diluted share related to a favorable insurance settlement and a benefit of $0.02 per diluted share related to a reduction in deferred tax asset valuation allowance, which compares to the Company’s previous guidance for the fourth quarter of earnings per diluted share in the range of $0.35 to $0.60.
HEPA 2.20 - plunging this one here a bit while the Feb$2.50 covered calls are currently offering (at .35) a 16% premium with a potential additional .30 gain should the stock get above 2.50.
BGFV 12.10 - anyone going to watch today's investor conference? Awesome numbers to tout to investors, oui oui...
Investor Presentation
As previously announced, Steven G. Miller, the Company’s Chairman, President and Chief Executive Officer, and Barry Emerson, the Company’s Sr. Vice President and Chief Financial Officer, will be presenting at the 23rd Annual ICR Conference. The Company’s presentation is scheduled to begin at 12:30 pm Eastern time today, Wednesday, January 13, 2021. The presentation will be broadcast live over the Internet and accessible through the Investor Relations section of the Company’s website at www.big5sportinggoods.com. Visitors to the website should select the “Investor Relations” link to access the webcast. The webcast will be available on the same website following the presentation.
BGFV 11.90 - re-entered on that very bright news.